Vance Warren

Pharmacokinetics, Safety, and Tolerability of the Oral Renin Inhibitor Aliskiren in Patients With Hepatic Impairment

Sujata Vaidyanathan, Vance Warren, Ching‐Ming Yeh et al. · The Journal of Clinical Pharmacology · 2007 · 61 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

A first‐in‐human study of DS‐1040, an inhibitor of the activated form of thrombin‐activatable fibrinolysis inhibitor, in healthy subjects

Jin Zhou, Jarema Kochan, Ophelia Yin et al. · Journal of Thrombosis and Haemostasis · 2017 · 35 citations · Full text

Medicine, Pharmacology, Clinical Biochemistry +13

Tolerability, pharmacokinetics, and pharmacodynamics of mirogabalin in healthy subjects: Results from phase 1 studies

Karen Brown, Jeanne Mendell, Shoichi Ohwada et al. · Pharmacology Research & Perspectives · 2018 · 31 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects

Sujata Vaidyanathan, Mojdeh Maboudian, Vance Warren et al. · Current Medical Research and Opinion · 2008 · 23 citations

Medicine, Pharmacokinetics, Pharmacology +17

Abuse potential of mirogabalin in recreational polydrug users

Jeanne Mendell, Naama Levy‐Cooperman, Ed Sellers et al. · Therapeutic Advances in Drug Safety · 2019 · 19 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11